首页> 外文期刊>Indian drugs >ENANTIOSELECTIVE ANALYSIS OF GUAIFENESIN IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY CHIRAL REVERSE PHASE HPLC-PDA METHOD
【24h】

ENANTIOSELECTIVE ANALYSIS OF GUAIFENESIN IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY CHIRAL REVERSE PHASE HPLC-PDA METHOD

机译:手性反相HPLC-PDA方法对散装和药物剂型的植物和药物剂型对映选择性分析

获取原文
获取原文并翻译 | 示例
       

摘要

A novel, accurate and precise chiral reverse-phase high pressure liquid chromatographic method was developed for enantioselective analysis of guaifenesin (GFN) in bulk and tablet dosage forms. Chiral separation was achieved on Phenomenex Lux Cellulose-4 column (250 × 4.6mm, 5u) using 0.02% formic acid: acetonitrile (90:10 V/V) as the mobile phase at a flow rate of 1mL/min at 230nm. The retention times of GFN enantiomers A and B was 15 and 16 minutes, respectively, with good peak resolutions and showing good linearity in the concentration range of 10-50 ug/mL (R~2 > 0.999). The developed method was validated as per the International Conference on Harmonization guidelines and the results were well within the acceptable limits. The percentage assay in tablet dosage form was found to be 98.8 and 98.2 respectively, for enantiomers A and B and was with in the compendial specifications, demonstrating the suitability of developed method for enantioselective analysis of guaifenesin racemic mixture.
机译:开发了一种新颖,准确和精确的手性反相高压液相色谱法,用于散装和片剂剂型的愈合蛋白(GFN)对映选择性分析。使用0.02%甲酸:乙腈(90:10V / v)作为流动率,以1mL / min在230mm的流速为流动阶段,实现手性分离。 GFN对映体A和B的保留时间分别为15和16分钟,分别具有良好的峰值分辨率,并在10-50μg/ ml(R〜2> 0.999)的浓度范围内显示出良好的线性性。根据协调指南的国际会议验证开发的方法,结果在可接受的限度范围内。将片剂剂型中的百分比分别为98.8和98.2分别用于对映体A和B,并在竞争规范中,表明了开发方法对愈合的愈合蛋白外消旋混合物的映射性分析的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号